CADTH | Evidence Driven
CADTH | Evidence Driven

Search CADTH

Filters

No filters applied.

Showing 41 - 50 results of 3649

Download as CSV

Golimumab (Simponi I.V.) (Last Updated: Sep 12, 2013)

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indications

Brand Name:
Simponi I.V.
Manufacturer:
Janssen Inc.
Submission Type:
Initial
Indications:

Arthritis, Rheumatoid

Riociguat (Adempas) (Last Updated: Sep 30, 2013)

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indications

Brand Name:
Adempas
Manufacturer:
Bayer Inc.
Submission Type:
Initial
Indications:

Pulmonary hypertension, chronic thromboembolic

Teriflunomide (Aubagio) (Last Updated: Aug 28, 2013)

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indications

Brand Name:
Aubagio
Manufacturer:
Genzyme Canada, a Division of Sanofi Aventis Canada Inc.
Submission Type:
Initial
Indications:

Multiple Sclerosis, relapsing

Saxagliptin + Metformin (Komboglyze) (Last Updated: Aug 23, 2013)

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indications

Brand Name:
Komboglyze
Manufacturer:
AstraZeneca Canada Inc.
Submission Type:
Initial
Indications:

Diabetes Mellitus, Type 2

Simeprevir (Galexos) (Last Updated: Aug 22, 2013)

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indications

Brand Name:
Galexos
Manufacturer:
Janssen Inc.
Submission Type:
Initial
Indications:

Hepatitis C, chronic

Phleum pratense (Grastek) (Last Updated: Sep 30, 2013)

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indications

Brand Name:
Grastek
Manufacturer:
Merck Canada Inc.
Submission Type:
Initial
Indications:

Allergy (grass)

Rotigotine (Neupro) (Last Updated: Jul 31, 2013)

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indications

Brand Name:
Neupro
Manufacturer:
UCB Canada Inc.
Submission Type:
Initial
Indications:

Parkinson’s Disease

Zydelig for Chronic Lymphocytic Leukemia – Details (Zydelig) (Last Updated: Sep 2, 2015)

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indication

Brand Name:
Zydelig
Manufacturer:
Gilead Sciences, Inc.
Submission Type:
Initial

Keytruda for Metastatic Melanoma – Details (Keytruda) (Last Updated: Dec 1, 2015)

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indication

Brand Name:
Keytruda
Manufacturer:
Merck Canada Inc.
Submission Type:
Initial